1.Cerebral Venous Malformation:Imaging Diagnosis and Evaluation
Journal of Practical Radiology 2001;0(07):-
Objective To evaluate the value and limitation of CTA, MRI and DSA in the diagnosis of the cerebral venous malformation. Methods CT angiography in 8 cases and MRI in 10 cases were performed among 12 cases of cerebral venous malformation confirmed by carotid angiography . Results All cases had typical DSA appearance and it could be seen both the number and the direction of the guide vein. The typical “Medusa-head” sign could be seen on MRI and could be more obvious after contrast enhancement.The other complications might be seen on the postcontrast. On CTA,both the lesion itself and the “caput medusae”sign could be displayed.Conclusion In diagnosis of cerebral venous malformation,DSA is the gold standard,CTA is the significant method in diagnosing and following up,while MRI is the most useful method.
3.Uterine papillary serous carcinoma: report of a case.
Chinese Journal of Pathology 2009;38(8):557-558
Aged
;
CA-125 Antigen
;
metabolism
;
Carcinoembryonic Antigen
;
metabolism
;
Cystadenocarcinoma, Papillary
;
metabolism
;
pathology
;
surgery
;
Female
;
Humans
;
Keratin-7
;
metabolism
;
Ki-67 Antigen
;
metabolism
;
Membrane Proteins
;
metabolism
;
Uterine Neoplasms
;
metabolism
;
pathology
;
surgery
4.Nodal and ovarian matastases in leiomyosaromas of uterus: report of a case.
Chinese Journal of Pathology 2010;39(10):714-715
Calmodulin-Binding Proteins
;
metabolism
;
Female
;
Humans
;
Hysterectomy
;
Leiomyosarcoma
;
metabolism
;
pathology
;
secondary
;
surgery
;
Lymph Node Excision
;
Lymph Nodes
;
pathology
;
Lymphatic Metastasis
;
Middle Aged
;
Neprilysin
;
metabolism
;
Ovarian Neoplasms
;
secondary
;
Uterine Neoplasms
;
metabolism
;
pathology
;
surgery
5.Intraocular pressure after intravitreal injection of drugs
Shuang SONG ; Hong DAI ; Xiaobing YU
Chinese Journal of Ocular Fundus Diseases 2016;32(4):453-457
Corticosteroids,anti-vascular endothelial growth factor,antibiotics and antiviral were the main 4 classes of drugs for intravitreal injection.Depending on the class and volume of medication,age and gender of patients,ocular axial lengths or vitreous humour reflux,intraocular pressure (IOP) can be elevated transiently or persistently after intravitreal injection.Transient IOP elevation occurred in 2 weeks after intravitreal injection,and can be reduced to normal level for most patients.Only a small portion of such patients have very high IOP and need intervention measures such as anterior chamber puncture or lowering intraocular pressure by drugs.Long term IOP elevation is refers to persistent IOP increase after 2 weeks after intravitreal injection,and cause optic nerve irreversible damage and decline in the visual function of patients.Thus drug or surgical intervention need to be considered for those patients with high and long period of elevated IOP.Large-scale multicenter clinical trials need to be performed to evaluate the roles of the drug and patients factors for IOP of post-intravitreal injection,and to determine if it is necessary and how to use methods reducing IOP before intravitreal injection.
6.The efficacy of intravitreal ranibizumab and (or)triamcinolone combined with laser photocoagulation for macular edema secondary to branch retinal vein occlusion
Shuang SONG ; Xiaobing YU ; Hong DAI
Chinese Journal of Ocular Fundus Diseases 2015;31(1):18-21
Objective To investigate the efficacy and safety of intravitreal ranibizumab and (or) triamcinolone combined with laser photocoagulation for macular edema secondary to branch retinal vein occlusion (BRVO) during one year period.Methods The data of 31 eyes from 31 consecutive patients with macular edema secondary to BRVO during one year follow-up visit were retrospectively analyzed.Mean best corrected visual acuity (BCVA) logMAR was (0.74±0.36) and mean central retinal thickness (CRT) was (484.48± 164.81) μm at baseline.All patients received standardized clinical comprehensive examinations including vision,intraocular pressure and optical coherence tomography for diagnosis before treatment.All patients received intravitreal injections of 0.5 mg ranibizumab (0.05 ml) at first visit.The continue PRN treatment were based on the visual acuity changes and the optical coherence tomography findings.Eyes received combined triamcinolone acetonide 0.05 ml (40 mg/ml) and ranibizumab for macular edema recurrence after two injections of ranibizumab and received laser photocoagulation during 10-14 days after third injections of ranibizumab.Mean injection of ranibizumab was 3.52± 2.01,15 eyes with triamcinolone acetonide (0.84 ± 1.21),21 eyes with laser photocoagulation (0.97± 0.95) and 12 eyes with three treatment.Compared the visual acuities and CRTs of the first and the last visits by statistical analysis.Results Mean visual acuity improved significantly to 0.42±0.33 logMAR (t=6.611,P=0.000).Mean improvement of visual acuity was 2.90± 3.07 lines.A gain of three or more logarithmic lines was evaluated in 20/31 eyes (64.52%) at the last visit.Mean CRT was (326.19± 117.80) μm (t=4.514,P=0.000).Mean reduction of CRT was (333.58±134.17) μm.A decrease of 100 μm of CRT was evaluated in 17/31 eyes (54.84%).No severe ocular and systematic side effect was found.Conclusion The efficacy and safety of intravitreal ranibizumab and (or) triamcinolone combined with laser photocoagulation for macular edema secondary to BRVO were assured.
7.Status Quo of Pharmaceutical Administration in Primary Hospitals in View of Inspection Results of Pharmaceutical Administration of 7 Hospitals from Pengzhou City
Dan DAI ; Li SONG ; Jihong DENG
China Pharmacy 2007;0(29):-
OBJECTIVE: To investigate the status quo of pharmaceutical administration in primary hospitals.METHODS: According to the requirements of 2009 "Medical quality promotional campaign around China" held by Ministry of Public Health,pharmaceutical care of 7 hospitals in Pengzhou city were evaluated and scored in accordant with the detailed rules.The scoring percentages were calculated and pharmaceutical care of 7 hospitals were analyzed.RESULTS & CONCLUSIONS: The scoring percentages of 2 hospitals were more than 80%;those of 3 hospitals were between 60% and 80%;those of 2 hospitals were lower than 60%.No hospital had obtained score in the field of clinical pharmacy.In primary hospital several aspects should be strengthened,such as pharmaceutical professional staff,system construction,rational use of drugs and clinical pharmaceutical care.
8.Radiology features of giant cell tumors of the skull
Shixin YAN ; Song JIN ; Weiying DAI
Chinese Journal of Orthopaedics 2001;0(08):-
Objective To analyze the CT and MRI features of giant cell tumors of the skull. Methods 8 cases of giant cell tumors of the skull proven surgically and pathologically were analyzed retrospectively. CT and MRI(6 cases with post contrast CT and 5 cases with post contrast MRI scans)were performed in all cases. All tumors were excised surgically. Two weeks later,all patients undertook postoperative radiotherapy with the dosage of 4 500-6 000 cGy for five to six weeks. Results CT scan showed bone destruction and calcification. Most of the tumours were well defined with low signal intensities on T1 WI images, T2 WI images showed ununiformity signal. The low signal on T1 WI was still low signal intensity on T2 WI which suggested calcification. All patients had no distinctive change within the follow up period. Conclusion CT is able to clearly show bone destruction and calcification. MRI is superior to CT in demonstrating the outlines of the tumours. CT and MRI are effective methods in the diagnosis of the giant cell tumors. Surgery and postoperative radiotherapy are effective methods in the treatment of the giant cell tumors.
9.Protective Effects of Neferine on Lipopolysaccharide-induced Human Umbilical Vein Endothelial Injury
Zhun DAI ; Jinchun SONG ; Xiaoqing YANG
China Pharmacist 2016;19(10):1875-1878
Objective:To investigate the protective effects of neferine on lipopolysaccharide ( LPS)-induced human umbilical vein endothelial cells ( HUVECs) injury. Methods:The optimum inducing concentration of LPS was screened out through pretests and used for the model establishment of HUVECs damage. CCK8 was used to detect the influence of neferine at different concentrations on LPS-induced human umbilical vein endothelial cells ( HUVECs) injury. Nitric oxide ( NO) content was measured by the Griess Reagent method. The nitric-oxide synthase (NOS) activity was assessed by the commercially available kits. Results:The inhibitory rate of HU-VECs was 54. 50% detected by CCK8, which induced by LPS at the concentration of 100 μg·ml-1(P<0. 01). Neferine at the con-centrations of 0. 3-5. 0μmol·L-1 could increase the cell viability in a concentration-dependent manner, while it inhibited the cell pro-liferation at the concentration of 10 μmol·L-1(P<0.05). Neferine could reverse the situation, and the NO release was increased and the tNOS/iNOS activity was increased induced by LPS (P<0. 05). The results shown by the inverted microscope suggested that the floating dead cells were decreased, the cell shape was basically sound and tightly packed with the concentration increase of neferine (0. 3-5. 0μmol·L-1) in a concentration-dependent manner. Conclusion:The results show that neferine has protective effects on HU-VECs injury induced by LPS, and the mechanism may be related with the decrease of intracellular levels of NO and NOS activity.